| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 4, 2006
From the Masonic Medical Research Laboratory (C.A., G.D.P., J.M.C., H.A., A.G., R.P., A.O., E.B., Y.W.), Utica, NY; Nora Eccles Harrison Cardiovascular Research and Training Institute (O.C., M.C.S., J.D.S.), University of Utah, Salt Lake City, Utah; Center for Molecular Medicine Cologne (B.W.), Institute of Human Genetics, University of Cologne, Germany; Cardiovascular Consultants of Long Island (P.G., E.P.B.), New Hyde Park, NY; Department of Internal Medicine (S.S., R.O.), Academic Hospital Oberhausen, Oberhausen, Germany; University of Wisconsin Medical School (A.B.), Milwaukee, Wis; Hopital Cardiologique du Haut-Leveque (L.-F.H., M.H.), Bordeaux, France; and 1st Department of Medicine-Cardiology (R.S., M.B., C.W.), University Hospital Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Mannheim, Germany. Dr Oliva is currently at the Catholic University in Rome, Italy. * To whom correspondence should be addressed. E-mail: ca{at}mmrl.edu.
Background--Cardiac ion channelopathies are responsible for an ever-increasing number and diversity of familial cardiac arrhythmia syndromes. We describe a new clinical entity that consists of an ST-segment elevation in the right precordial ECG leads, a shorter-than-normal QT interval, and a history of sudden cardiac death. Methods and Results--Eighty-two consecutive probands with Brugada syndrome were screened for ion channel gene mutations with direct sequencing. Site-directed mutagenesis was performed, and CHO-K1 cells were cotransfected with cDNAs encoding wild-type or mutant CACNB2b (Cav Conclusions--This is the first report of loss-of-function mutations in genes encoding the cardiac L-type calcium channel to be associated with a familial sudden cardiac death syndrome in which a Brugada syndrome phenotype is combined with shorter-than-normal QT intervals.
Accepted on November 22, 2006
Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death
Charles Antzelevitch PhD*,
2b), CACNA2D1 (Cav
2
1), and CACNA1C tagged with enhanced yellow fluorescent protein (Cav1.2). Whole-cell patch-clamp studies were performed after 48 to 72 hours. Three probands displaying ST-segment elevation and corrected QT intervals
360 ms had mutations in genes encoding the cardiac L-type calcium channel. Corrected QT ranged from 330 to 370 ms among probands and clinically affected family members. Rate adaptation of QT interval was reduced. Quinidine normalized the QT interval and prevented stimulation-induced ventricular tachycardia. Genetic and heterologous expression studies revealed loss-of-function missense mutations in CACNA1C (A39V and G490R) and CACNB2 (S481L) encoding the
1- and
2b-subunits of the L-type calcium channel. Confocal microscopy revealed a defect in trafficking of A39V Cav1.2 channels but normal trafficking of channels containing G490R Cav1.2 or S481L Cav
2b-subunits.
Related Article:
Circulation 2007 115: 427.
This article has been cited by other articles:
![]() |
M. Chahine Cardiac Metabolic State and Brugada Syndrome: A Link Revealed Circ. Res., October 9, 2009; 105(8): 721 - 723. [Full Text] [PDF] |
||||
![]() |
C. Veltmann, C. Wolpert, F. Sacher, P. Mabo, R. Schimpf, F. Streitner, J. Brade, F. Kyndt, J. Kuschyk, H. Le Marec, et al. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges Europace, October 1, 2009; 11(10): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Sinner, A. Pfeufer, S. Perz, E. Schulze-Bahr, G. Monnig, L. Eckardt, B.-M. Beckmann, H.-E. Wichmann, G. Breithardt, G. Steinbeck, et al. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study Europace, October 1, 2009; 11(10): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Catalano, S. Antonaci, G. Moro, M. Mussida, M. Frascaroli, M. Baldi, F. Cobelli, P. Baiardi, J. Nastoli, R. Bloise, et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities Eur. Heart J., September 2, 2009; 30(18): 2241 - 2248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G. Yap, E. R. Behr, and A. J. Camm Drug-induced Brugada syndrome Europace, August 1, 2009; 11(8): 989 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Thomsen, C. Wang, N. Ozgen, H.-G. Wang, M. R. Rosen, and G. S. Pitt Accessory Subunit KChIP2 Modulates the Cardiac L-Type Calcium Current Circ. Res., June 19, 2009; 104(12): 1382 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hu, H. Barajas-Martinez, E. Burashnikov, M. Springer, Y. Wu, A. Varro, R. Pfeiffer, T. T. Koopmann, J. M. Cordeiro, A. Guerchicoff, et al. A Mutation in the {beta}3 Subunit of the Cardiac Sodium Channel Associated With Brugada ECG Phenotype Circ Cardiovasc Genet, June 1, 2009; 2(3): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Veltmann, M. Borggrefe, R. Schimpf, and C. Wolpert Yew Causes Brugada ECG Circulation, April 7, 2009; 119(13): 1836 - 1837. [Full Text] [PDF] |
||||
![]() |
A. O. Grant Cardiac Ion Channels Circ Arrhythm Electrophysiol, April 1, 2009; 2(2): 185 - 194. [Full Text] [PDF] |
||||
![]() |
K. Calloe, J. M. Cordeiro, J. M. Di Diego, R. S. Hansen, M. Grunnet, S. P. Olesen, and C. Antzelevitch A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome Cardiovasc Res, March 1, 2009; 81(4): 686 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gaborit, T. Wichter, A. Varro, V. Szuts, G. Lamirault, L. Eckardt, M. Paul, G. Breithardt, E. Schulze-Bahr, D. Escande, et al. Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases Eur. Heart J., February 2, 2009; 30(4): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zumhagen, T. Spieker, J. Rolinck, H. A. Baba, G. Breithardt, W. Bocker, L. Eckardt, M. Paul, T. Wichter, and E. Schulze-Bahr Absence of Pathognomonic or Inflammatory Patterns in Cardiac Biopsies From Patients With Brugada Syndrome Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth CHAPTER 9 Genetics of Cardiovascular Diseases ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Antoons and K. R. Sipido Targeting calcium handling in arrhythmias Europace, December 1, 2008; 10(12): 1364 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. London Understanding Cardiac Calcium Channelopathies Circulation, November 25, 2008; 118(22): 2221 - 2222. [Full Text] [PDF] |
||||
![]() |
P. A. Noseworthy and C. Newton-Cheh Genetic Determinants of Sudden Cardiac Death Circulation, October 28, 2008; 118(18): 1854 - 1863. [Full Text] [PDF] |
||||
![]() |
E. Delpon, J. M. Cordeiro, L. Nunez, P. E. B. Thomsen, A. Guerchicoff, G. D. Pollevick, Y. Wu, J. K. Kanters, C. T. Larsen, E. Burashnikov, et al. Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 209 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Petitprez, T. Jespersen, E. Pruvot, D. I. Keller, C. Corbaz, J. Schlapfer, H. Abriel, and J. P. Kucera Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome Cardiovasc Res, June 1, 2008; 78(3): 494 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Francis and C. Antzelevitch Atrial Fibrillation and Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1149 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-S. Chen and S. G. Priori The Brugada Syndrome J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1176 - 1180. [Full Text] [PDF] |
||||
![]() |
S. Viskin, C. Antzelevitch, M. F. Marquez, and B. Belhassen Quinidine: a valuable medication joins the list of 'endangered species' Europace, December 1, 2007; 9(12): 1105 - 1106. [Full Text] [PDF] |
||||
![]() |
B. London, M. Michalec, H. Mehdi, X. Zhu, L. Kerchner, S. Sanyal, P. C. Viswanathan, A. E. Pfahnl, L. L. Shang, M. Madhusudanan, et al. Mutation in Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias Circulation, November 13, 2007; 116(20): 2260 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Viswanathan and R. L. Page Short QT: When Does It Matter? Circulation, August 14, 2007; 116(7): 686 - 688. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |